CSI Market
Sign In | Register

Lineage Cell Therapeutics Inc (LCTX) Annual Balance Sheets

Annual · GAAP · USD millions
Access LCTX quarterly Balance Sheets →
From Lineage Cell Therapeutics Inc through Dec 31 2021, shifts in Dec 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent40.79
Marketable Securities, Current SH14.99
Cash & Short-term Investments54.00
Accounts receivable0.89
Other Current Assets0.00
Prepaid Expense And Other Assets Current2.49
Total Current Assets59.16
Equipment/Property/Plant Net2.57
Goodwill net10.67
Intangible Assets31.70
Deposits Assets, Noncurrent AS0.00
Other Assets, Noncurrent8.49
Total Assets112.58
Liabilities
Accounts Payable and Accrued Liabilities, Current LI7.18
Other Liabilities, Current0.85
Deferred Revenue, Current DE3.33
Total Current Liabilities11.37
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE43.91
Deferred Revenue, Noncurrent DE12.38
Other liabilities, Noncurrent1.59
Liability Classified Warrants Current Portion-
Finance Lease Liability Current0.04
Total Liabilities69.24
Stockholders' Equity
Common Stock Value515.47
Retained Earnings / Accumulated Deficit-467.00
Other Equity-3.92
Common Stockholder's Equity44.55
Non-controlling interests & other-1.20
Total Stockholder's Equity43.35
Liabilities & Stockholder's Equity112.58
4 historic quarters locked

Sign in to unlock the full Lineage Cell Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Lineage Cell Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-093992

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License